Category: General In Vitro Diagnostics
Global General In Vitro Diagnostics
-
The 2026-2031 World Outlook for Efficacy Testing Consumables
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for ADME-Toxicology Testing
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Acute Myeloid Testing
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Arbovirus Testing
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for At-Home Drug of Abuse Testing
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Roadside Drug Testing Devices
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Invasive Helicobacter Pylori Diagnostics
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Efficacy Testing
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Alcohol Breathalyzer and Drugs Testing Equipment
... the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. ... Read More
-
The 2026-2031 World Outlook for Automated-Method Blood Culture Tests
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 Billion by ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Helicobacter Pylori Diagnostics
... at a CAGR of 4.8% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by the end of the ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Immunoturbidimetric Assay, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$1.9 Billion by the end of ... Read More
-
Paper Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More
-
Sepsis Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Microbiology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis period. ... Read More
-
In Vitro Toxicology Testing
... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by the ... Read More
-
Rabies Diagnostics
... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end of ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Prenatal Diagnostics
... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
Research Assistance
